Literature DB >> 7104494

Identification of the molecular defect in the erythrocyte membrane skeleton of some kindreds with hereditary spherocytosis.

S R Goodman, K A Shiffer, L A Casoria, M E Eyster.   

Abstract

We have localized the molecular alteration in the membrane skeleton of two of four kindreds with hereditary spherocytosis (HS) to an alteration in the spectrin-protein-4.1 interaction due to a defective spectrin molecule. The defective spectrin-protein-4.1 interaction in these kindreds (referred to as type I HS) leads to a weakened spectrin-protein-4.1-actin ternary complex, which in turn may lead to the friable membrane skeleton and suggested membrane instability related to this disorder. Type I HS spectrin binds approximately 63% as much protein-4.1 as normal spectrin (with equal affinity). This defect does not correlate with splenic function or erythrocyte age in the circulation. However, the approximately 37% reduction in binding of protein-4.1 to HS spectrin approaches the theoretical value of 50% expected in this autosomal dominant disorder. All other type I membrane skeletal interactions (spectrin-syndein, spectrin heterodimer-heterodimer, syndein-band-3) were found to be normal. It would appear therefore that the defective HS spectrin-protein-4.1 interaction in type I hereditary spherocytosis may be the primary molecular defect rather than a secondary phenomena.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104494

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Alteration in membrane protein band 3 associated with accelerated erythrocyte aging.

Authors:  M M Kay; N Flowers; J Goodman; G Bosman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes.

Authors:  M M Kay; G J Bosman; C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Immunocytochemical study of membrane skeletons in abnormally shaped erythrocytes as revealed by a quick-freezing and deep-etching method.

Authors:  S Ohno; N Terada; Y Fujii; H Ueda; H Kuramoto; N Kamisawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  A de novo 1.5 Mb microdeletion on chromosome 14q23.2-23.3 in a patient with autism and spherocytosis.

Authors:  Anthony J Griswold; Deqiong Ma; Stephanie J Sacharow; Joycelyn L Robinson; James M Jaworski; Harry H Wright; Ruth K Abramson; Helle Lybaek; Nina Øyen; Michael L Cuccaro; John R Gilbert; Margaret A Pericak-Vance
Journal:  Autism Res       Date:  2011-02-28       Impact factor: 5.216

5.  Two distinct variants of erythrocyte spectrin beta IV domain.

Authors:  B Pothier; N Alloisio; L Morlé; J Maréchal; H Barthélemy; M T Ducluzeau; A Dorier; J Delaunay
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

6.  Membrane protein lesions in erythrocytes with Heinz bodies.

Authors:  O S Platt; J F Falcone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 7.  Human chromosome 8.

Authors:  S Wood
Journal:  J Med Genet       Date:  1988-11       Impact factor: 6.318

8.  Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation.

Authors:  L C Wolfe; A M Byrne; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Senescent cell antigen is immunologically related to band 3.

Authors:  M M Kay; S R Goodman; K Sorensen; C F Whitfield; P Wong; L Zaki; V Rudloff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding.

Authors:  P S Becker; J S Morrow; S E Lux
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.